Bioorganic and Medicinal Chemistry Letters p. 591 - 596 (2004)
Update date:2022-08-04
Topics:
Dyatkin, Alexey B.
Hoekstra, William J.
Kinney, William A.
Kontoyianni, Maria
Santulli, Rosemary J.
Kimball, Edward S.
Fisher, M. Carolyn
Prouty, Stephen M.
Abraham, William M.
Andrade-Gordon, Patricia
Hlasta, Dennis J.
He, Wei
Hornby, Pamela J.
Damiano, Bruce P.
Maryanoff, Bruce E.
The design, synthesis, and biological activity of novel α 4β1 and α4β7 integrin antagonists, containing a bridged azabicyclic nucleus, are reported. Conformational analysis of targets containing an azabicyclo[2.2.2]octane carboxylic acid and known integrin antagonists indicated that this azabicycle would be a suitable molecular scaffold. Variation of substituents on the pendant arylsulfonamide and phenylalanine groups resulted in potent α 4β1-selective and dual α4β 1/α4β7 antagonists. Potent compounds 11i, 11h, and 14 were effective in the antigen-sensitized sheep model of asthma. 2003 Elsevier Science Ltd. All rights reserved.
View MoreHebei Think-Do Environment Co., Ltd
website:http://www.thinkdo-environment.com
Contact:0311-86510809
Address:No 6, Shilian Middle Street, Circular Chemical Industry Park
Contact:86-21 60347964
Address:No.1304, West Meilong Road, Minhang District, Shanghai, China
Hefei EnliPharma Tecnology Co.,Ltd
Contact:0086-551-66399836
Address:Qing Cheng ShuiXiang Building 805, Mengcheng North Road , ShuangFeng Economic Development Zone Anhui HeFei
NanJing Rate Biochemicals CO., LTD
Contact:+86-25-84931986
Address:NO. 1 Hongjing Road,Jiangning Science Park,Nanjing,China
Contact:+86-15850770348
Address:51 OF XIANGFANGCUN ROAD, Nanjing 210002, China
Doi:10.1039/b600195e
(2006)Doi:10.1016/0039-128X(95)00008-E
(1995)Doi:10.1007/BF00765967
(1983)Doi:10.1021/jo00030a009
(1992)Doi:10.1016/S0378-4274(02)00372-7
(2003)Doi:10.1007/BF00954710
(1983)